Makoto Hirakane is a notable inventor based in Rensselaer, NY (US). He has made significant contributions to the field of biochemistry, particularly in the synthesis of heparin. With a total of three patents to his name, Hirakane's work focuses on developing alternatives to traditional heparin sources.

Latest Patents

Hirakane's latest patents include innovative methods for synthesizing biosynthetic heparin. This synthesis aims to create a product that is bioequivalent to porcine USP Heparin Sodium. The process involves three intermediates starting from heparosan. Another significant patent involves the enzymatic preparation of increased anticoagulant bovine-sourced heparin. This patent discloses a method for enhancing the anticoagulant activity of heparin by treating it with a heparan sulfate sulfotransferase. The resulting heparin structure exhibits improved binding to antithrombin III and increased anticoagulant activity, making it a viable alternative to porcine intestinal heparin.

Career Highlights

Hirakane is affiliated with Rensselaer Polytechnic Institute, where he conducts his research and development work. His innovative approaches to heparin synthesis have positioned him as a key figure in the field of anticoagulant research.

Collaborations

Some of Hirakane's notable coworkers include Li Fu and Kevin Li. Their collaborative efforts contribute to the advancement of research in heparin synthesis and its applications.

Conclusion

Makoto Hirakane's contributions to the field of heparin synthesis highlight his innovative spirit and dedication to advancing medical science. His patents reflect a commitment to developing effective alternatives to traditional heparin sources.

This text is generated by artificial intelligence and may not be accurate.